{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for "Dietary Supplement Label Database|botanical" in comments (approximate match)
Status:
Possibly Marketed Outside US
Source:
Arm Slimming Patch by Guangzhou Hanhai Trading Co., Ltd
(2023)
Source URL:
First approved in 2023
Source:
Arm Slimming Patch by Guangzhou Hanhai Trading Co., Ltd
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
JBA Hello Healthy Glucose Cacao Healing Herbs for Blood Glucose Support With GlucoTrojan Reducose and ABALife Fig Extract by Advanced Pharmaceutical Services, Inc. Dba Affordable Quality Pharmaceuticals
(2023)
Source URL:
First approved in 2023
Source:
JBA Hello Healthy Glucose Cacao Healing Herbs for Blood Glucose Support With GlucoTrojan Reducose and ABALife Fig Extract by Advanced Pharmaceutical Services, Inc. Dba Affordable Quality Pharmaceuticals
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
NCT02069106: Phase 4 Interventional Withdrawn Mixed Hyperlipoproteinemia
(2014)
Source URL:
First approved in 2022
Source:
Dexinling by Shenzhen Deyintang Biotechnology Co., Ltd.
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
HempSeed Cordyceps by Tong Cheon Dang
(2022)
Source URL:
First approved in 2022
Source:
HempSeed Cordyceps by Tong Cheon Dang
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
NCT01590667: Phase 4 Interventional Completed Healthy Subjects
(2012)
Source URL:
First approved in 2021
Source:
M020
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
M016
(2023)
Source URL:
First approved in 2021
Source:
M016
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
21 CFR 356
(2020)
Source URL:
First approved in 2020
Source:
21 CFR 356
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
M004
(2020)
Source URL:
First approved in 2020
Source:
M004
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
M012
(2019)
Source URL:
First approved in 2019
Source:
M012
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
MINOXIGAINE by Hairgenics LLC
(2019)
Source URL:
First approved in 2019
Source:
MINOXIGAINE by Hairgenics LLC
Source URL:
Class:
STRUCTURALLY DIVERSE